About Shenandoah Therapeutics
Shenandoah Therapeutics is a private company based in South San Francisco, California, incorporated in 2022 in Delaware. It has reported $21,499,989 raised in one offering on Form D since May 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 2, 2025 | May 15, 2025 | $21,499,989fully sold | 12 | $1.7M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Shenandoah Therapeutics's Form D filed May 15, 2025.
MS
Mark Stepka
Executive officer
GY
Gary Yeung
Director
IG
Isabella Graef
Executive officer and director
WY
Wendy Young
Director
NG
Nathanael Gray
Director
JE
Jim Edwards
Director